Long-term glucocorticoid treatment increases CD204 expression by activating the MAPK pathway and enhances modified LDL uptake in murine macrophages

Atherosclerotic plaques develop from the accumulation of macrophage-derived foam cells via the uptake of modified low-density lipoprotein (LDL). CD36 and CD204 are the principal scavenger receptors responsible for the uptake of modified LDL. Although glucocorticoids are suspected to exacerbate ather...

Full description

Bibliographic Details
Main Authors: Ryota Hashimoto, Hiroshi Koide, Youichi Katoh
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Journal of Pharmacological Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S134786132200086X
_version_ 1811296259312451584
author Ryota Hashimoto
Hiroshi Koide
Youichi Katoh
author_facet Ryota Hashimoto
Hiroshi Koide
Youichi Katoh
author_sort Ryota Hashimoto
collection DOAJ
description Atherosclerotic plaques develop from the accumulation of macrophage-derived foam cells via the uptake of modified low-density lipoprotein (LDL). CD36 and CD204 are the principal scavenger receptors responsible for the uptake of modified LDL. Although glucocorticoids are suspected to exacerbate atherosclerosis, the precise mechanisms have not been fully elucidated. We investigated the effects of long-term treatment (2 weeks) with both a natural glucocorticoid (hydrocortisone, HC, 1 μM) and a synthetic glucocorticoid (dexamethasone, Dex, 100 nM) on murine bone marrow-derived macrophages using flow cytometry and western blotting. Treatment with HC and Dex enhanced CD204 expression but not CD36 expression and acetylated LDL (Ac-LDL) uptake. Treatment with HC and Dex also induced the phosphorylation of extracellular signal-regulated kinase (ERK). The Dex-induced enhancement in CD204 expression and Ac-LDL uptake were suppressed by an inhibitor of the mitogen-activated protein kinase (MAPK)/ERK kinase. These results suggest that glucocorticoids activate the MAPK/ERK pathway, which enhances CD204 expression and results in increased uptake of Ac-LDL in macrophages. The MAPK/ERK pathway in macrophages might be a key target to prevent atherosclerosis that is worsened by glucocorticoids.
first_indexed 2024-04-13T05:45:52Z
format Article
id doaj.art-618dc33ced1c46efb7b6905709dc5907
institution Directory Open Access Journal
issn 1347-8613
language English
last_indexed 2024-04-13T05:45:52Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series Journal of Pharmacological Sciences
spelling doaj.art-618dc33ced1c46efb7b6905709dc59072022-12-22T02:59:57ZengElsevierJournal of Pharmacological Sciences1347-86132023-01-0115114653Long-term glucocorticoid treatment increases CD204 expression by activating the MAPK pathway and enhances modified LDL uptake in murine macrophagesRyota Hashimoto0Hiroshi Koide1Youichi Katoh2Laboratory of Cell Biology, Biomedical Research Core Facilities, Juntendo University Graduate School of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, Japan; Department of Physiology, Juntendo University Faculty of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, Japan; Corresponding author. Laboratory of Cell Biology, Biomedical Research Core Facilities, Juntendo University Graduate School of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, Japan.Laboratory of Molecular and Biochemical Research, Biomedical Research Core Facilities, Juntendo University Graduate School of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, JapanDepartment of Cardiology, Juntendo University Graduate School of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, Japan; Juntendo University Faculty of International Liberal Arts, Hongo 2-1-1, Bunkyo-ku, Tokyo 112-8421, Japan; Corresponding author. Department of Cardiology, Juntendo University Graduate School of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, Japan.Atherosclerotic plaques develop from the accumulation of macrophage-derived foam cells via the uptake of modified low-density lipoprotein (LDL). CD36 and CD204 are the principal scavenger receptors responsible for the uptake of modified LDL. Although glucocorticoids are suspected to exacerbate atherosclerosis, the precise mechanisms have not been fully elucidated. We investigated the effects of long-term treatment (2 weeks) with both a natural glucocorticoid (hydrocortisone, HC, 1 μM) and a synthetic glucocorticoid (dexamethasone, Dex, 100 nM) on murine bone marrow-derived macrophages using flow cytometry and western blotting. Treatment with HC and Dex enhanced CD204 expression but not CD36 expression and acetylated LDL (Ac-LDL) uptake. Treatment with HC and Dex also induced the phosphorylation of extracellular signal-regulated kinase (ERK). The Dex-induced enhancement in CD204 expression and Ac-LDL uptake were suppressed by an inhibitor of the mitogen-activated protein kinase (MAPK)/ERK kinase. These results suggest that glucocorticoids activate the MAPK/ERK pathway, which enhances CD204 expression and results in increased uptake of Ac-LDL in macrophages. The MAPK/ERK pathway in macrophages might be a key target to prevent atherosclerosis that is worsened by glucocorticoids.http://www.sciencedirect.com/science/article/pii/S134786132200086XAtherosclerosisGlucocorticoidsScavenger receptorsUptake of modified LDLMAPK pathway
spellingShingle Ryota Hashimoto
Hiroshi Koide
Youichi Katoh
Long-term glucocorticoid treatment increases CD204 expression by activating the MAPK pathway and enhances modified LDL uptake in murine macrophages
Journal of Pharmacological Sciences
Atherosclerosis
Glucocorticoids
Scavenger receptors
Uptake of modified LDL
MAPK pathway
title Long-term glucocorticoid treatment increases CD204 expression by activating the MAPK pathway and enhances modified LDL uptake in murine macrophages
title_full Long-term glucocorticoid treatment increases CD204 expression by activating the MAPK pathway and enhances modified LDL uptake in murine macrophages
title_fullStr Long-term glucocorticoid treatment increases CD204 expression by activating the MAPK pathway and enhances modified LDL uptake in murine macrophages
title_full_unstemmed Long-term glucocorticoid treatment increases CD204 expression by activating the MAPK pathway and enhances modified LDL uptake in murine macrophages
title_short Long-term glucocorticoid treatment increases CD204 expression by activating the MAPK pathway and enhances modified LDL uptake in murine macrophages
title_sort long term glucocorticoid treatment increases cd204 expression by activating the mapk pathway and enhances modified ldl uptake in murine macrophages
topic Atherosclerosis
Glucocorticoids
Scavenger receptors
Uptake of modified LDL
MAPK pathway
url http://www.sciencedirect.com/science/article/pii/S134786132200086X
work_keys_str_mv AT ryotahashimoto longtermglucocorticoidtreatmentincreasescd204expressionbyactivatingthemapkpathwayandenhancesmodifiedldluptakeinmurinemacrophages
AT hiroshikoide longtermglucocorticoidtreatmentincreasescd204expressionbyactivatingthemapkpathwayandenhancesmodifiedldluptakeinmurinemacrophages
AT youichikatoh longtermglucocorticoidtreatmentincreasescd204expressionbyactivatingthemapkpathwayandenhancesmodifiedldluptakeinmurinemacrophages